[Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases].
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008314:Malonates / Q000627:therapeutic use; D008744:Methylamines / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D008314:Malonates; D008744:Methylamines; D014227:Triazines
Pharmakologische Eigenschaften und therapeutische Wirkung des Azapropazon beim rheumatischen Formenkreis.